Skip to main content
. 2020 May 4;10(5):48. doi: 10.1038/s41408-020-0318-1

Fig. 2. Survival outcomes by FLT3 numerical variation, length and allelic ratio.

Fig. 2

Overall survival and relapse free survival for all patients receiving FLT3 inhibitors (a, b) based on FLT3-ITD numerical variation (single versus multiple) (c, d) FLT3-ITD mutation length (Long versus Short) (e, f) FLT3-ITD allelic ratio (high ≥0.5, low <0.5).